Abstract |
Extracellular superoxide dismutase (EC-SOD) overexpression modulates cellular responses such as tumor cell suppression and is induced by IFNγ. Therefore, we examined the role of EC-SOD in IFNγ-mediated tumor cell suppression. We observed that the dominant-negative protein kinase C delta (PKCδ) suppresses IFNγ-induced EC-SOD expression in both keratinocytes and melanoma cells. Our results also showed that PKCδ-induced ECSOD expression was reduced by pretreatment with a PKCspecific inhibitor or a siRNA against PKCδ. PKCδ-induced ECSOD expression suppressed cell proliferations by the up-regulation of p21 and Rb, and the downregulation of cyclin A and D. Finally, we demonstrated that increased expression of EC-SOD drastically suppressed lung melanoma proliferation in an EC-SOD transgenic mouse via p21 expression. In summary, our findings suggest that IFNγ-induced EC-SOD expression occurs via activation of PKCδ. Therefore, the upregulation of EC-SOD may be effective for prevention of various cancers, including melanoma, via cell cycle arrest.
|
Authors | Yoon-Jae Jeon, Hyun Yoo, Byung Hak Kim, Yun Sang Lee, Byeongwook Jeon, Sung-Sub Kim, Tae-Yoon Kim |
Journal | BMB reports
(BMB Rep)
Vol. 45
Issue 11
Pg. 659-64
(Nov 2012)
ISSN: 1976-670X [Electronic] Korea (South) |
PMID | 23187006
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antiviral Agents
- RNA, Small Interfering
- Reactive Oxygen Species
- Interferon-gamma
- Sod3 protein, mouse
- Superoxide Dismutase
- Protein Kinase C-delta
|
Topics |
- Animals
- Antiviral Agents
(pharmacology)
- Blotting, Western
- Carcinoma, Squamous Cell
(drug therapy, metabolism, pathology)
- Cell Proliferation
(drug effects)
- Cells, Cultured
- Gene Expression Regulation, Enzymologic
(drug effects)
- Humans
- Interferon-gamma
(pharmacology)
- Keratinocytes
(drug effects, metabolism, pathology)
- Melanoma
(drug therapy, metabolism, pathology)
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Protein Kinase C-delta
(metabolism)
- RNA, Small Interfering
(genetics)
- Reactive Oxygen Species
(metabolism)
- Skin Neoplasms
(drug therapy, metabolism, pathology)
- Superoxide Dismutase
(antagonists & inhibitors, genetics, metabolism)
- Up-Regulation
|